4.5 Review

Vaccination in Southeast Asia-Reducing meningitis, sepsis and pneumonia with new and existing vaccines

Journal

VACCINE
Volume 32, Issue 33, Pages 4119-4123

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2014.05.062

Keywords

Streptococcal vaccines; Haemophilus vaccines; Meningococcal vaccines; Southeast Asia

Funding

  1. Pfizer Vaccines
  2. Pfizer
  3. Novartis

Ask authors/readers for more resources

Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis are leading causes of vaccine-preventable diseases such as meningitis, sepsis and pneumonia. Although there has been much progress in the introduction of vaccines against these pathogens, access to vaccines remains elusive in some countries. This review highlights the current S. pneumoniae, H. influenzae type b, and N. meningitidis immunization schedules in the 10 countries belonging to the Association of Southeast Asian Nations (ASEAN). Epidemiologic studies may be useful for informing vaccine policy in these countries, particularly when determining the cost-effectiveness of introducing new vaccines. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available